Low‐dose apatinib and tegafur‐gimeracil‐oteracil as palliative treatment in recurrent cervical cancer patients with poor performance status: A case series-Reference-Cited by-同舟云学术

Low‐dose apatinib and tegafur‐gimeracil‐oteracil as palliative treatment in recurrent cervical cancer patients with poor performance status: A case series

Published:2020-08 Issue:6 Volume:45 Page:1501-1504
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Xu Xiu‐Juan¹,Wang Zhong‐Ming¹,Shang Yu‐Ping¹,Jiang Shu‐Nian¹^ORCID

Affiliation:

1. Department of Radiation Oncology Lianyungang No 2 People's Hospital Lianyungang China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13241

Reference20 articles.

1. Ten years of HPV vaccines: State of art and controversies

2. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

3. Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up

4. Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study

5. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gimeracil/oteracil/tegafur/rivoceranib;Reactions Weekly;2021-02